Waldencast plc (WALD)
Nasdaq · Consumer Defensive · Household & Personal Products
$0.87940.00%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $112M
- 52-week range
- $0.72 – $3.22
- 52-week change
- −53.61%
- EPS (trailing)
- −$1.25
- Analyst rating
- 2.0 Buy
Fiscal year to Dec 2025
- Revenue
- $272M (−0.66%)
- Net income
- −$230M
- Operating margin
- −80.0%
- Diluted EPS
- −$2.01
- Free cash flow
- −$16.3M
From the company’s annual report on SEC EDGAR.
About Waldencast plc
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products. It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Headquarters: London, United Kingdom · 367 employees · waldencast.com